Home›Rheumatology› Lung Ultrasound Matches HRCT for ILD Screening in Rheumatoid Arthritis
Lung Ultrasound Matches HRCT for ILD Screening in Rheumatoid ArthritisLung Ultrasound Shows Promise for Screening Rheumatoid Arthritis Patients
medRxivPublished November 4, 2026Study authors: Copoeru, A. D.; Mocan, M.; Farcas, A.; Vlaicu, S.; Chira, R. I.DOI ↗Editorial oversight: Dr. Amelia Tan, PhD · Internal Medicine & Chronic Disease
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Lung ultrasound may be an effective screening alternative to HRCT for interstitial lung disease in rheumatoid arthritis, but protocols need standardization.
Interstitial lung disease is a serious complication of rheumatoid arthritis, and high-resolution computed tomography (HRCT) is the current gold standard for detection. A systematic review of 10 articles examined whether lung ultrasound (LUS) could serve as an effective screening alternative.
The review concluded that LUS is effective compared to HRCT as a screening tool for interstitial lung disease in patients with rheumatoid arthritis. Diagnostic and severity scores were among the secondary outcomes assessed across the included studies.
However, the authors highlighted important limitations. Protocols for LUS need standardization before the technique can be applied consistently across centers. In addition, future work should focus on long-term follow-up to clarify how screening findings translate into outcomes over time.
Safety data, funding sources, and conflicts of interest were not reported in the available review information. The certainty of the evidence and any causal inferences were also not described.
For clinicians, the findings suggest LUS may offer a practical, non-ionizing screening option for ILD in rheumatoid arthritis, though standardized protocols remain a prerequisite for routine use.
How this fits prior evidence
This systematic review on LUS for ILD screening in RA extends prior coverage of diagnostic and therapeutic advances in immune-mediated diseases. Previous items addressed treatment responses in psoriatic arthritis and psoriasis, immune mechanisms in systemic JIA versus adult RA, and a protocol for host-response biomarkers in periprosthetic joint infection. Unlike those, this review focuses on a non-invasive imaging modality for pulmonary complications in RA. It aligns with the broader theme of improving diagnosis and management in rheumatologic conditions, but the evidence remains limited by small study numbers and lack of standardization, contrasting with the more robust trial data covered for secukinumab in psoriatic arthritis.
Researchers reviewed several studies to see how well lung ultrasound (LUS) works as a screening tool. They specifically looked at patients with rheumatoid arthritis who may also have interstitial lung disease. The goal was to see if LUS could be a reliable way to check for lung issues.
The review of 10 articles found that lung ultrasound is effective compared to high-resolution computer tomography (HRCT) for screening. While HRCT is often considered the gold standard, the findings suggest that ultrasound is a comparable tool for identifying lung conditions in these patients.
Because this was a review of a small number of articles, there are some limitations. The researchers noted a need for more standardized protocols and more long-term follow-up data. Patients should talk to their doctors to see if lung ultrasound is a suitable screening option for their specific care plan.
What this means for you:
Lung ultrasound is an effective screening tool for lung disease in rheumatoid arthritis patients, similar to CT scans.
Common questions
Is lung ultrasound as good as a CT scan for screening?
The review of 10 articles found that lung ultrasound is effective compared to high-resolution computer tomography (HRCT) as a screening tool. This means it can be a reliable way to check for interstitial lung disease in patients with rheumatoid arthritis.
Who is this screening method for?
This specific finding applies to patients who have been diagnosed with rheumatoid arthritis. The study looked at how lung ultrasound can help identify interstitial lung disease within that specific patient group.
Are there any limitations to using lung ultrasound?
The review noted that there is a need for more standardized protocols and more long-term follow-up data. Because of these factors, you should discuss the best screening options with your doctor.
Interstitial lung diseases (ILD) associated with systemic autoimmune disease can have a strong negative impact on patient outcomes. The diagnostic gold standard is high-resolution computer tomography (HRCT). Numerous studies have proven lung ultrasound's (LUS) utility in ILD, as well as other lung pathologies. Recently, there has been more focus on ILD in rheumatoid arthritis (RA), a previously overlooked complication, and screening methods. The purpose of this systematic review was to summarize the recent knowledge regarding LUS compared to HRCT in screening ILD in RA patients. We reviewed relevant literature from the last 10 years and selected 10 articles. Results show that LUS is effective compared to HRCT as a screening tool. Several diagnostic and severity scores have been elaborated and tested. Further focus should be on LUS in long-term follow-up and standardization of protocols.
